India's Financial Express reports ("Domestic pharma cos fare well in patent litigation tests") on the pharma patent litigation success rates of India's leading pharmaceutical companies in US litigation over the past decade. Lupin Pharma has a success rate of 75%, while Sun Pharma (67%), Ranbaxy (63%) and Dr Reddy’s (61%) are not far behind. The article also gives a neat thumbnail sketch of the pharma patent litigation environment.
Showing posts with label Indian companies. Show all posts
Showing posts with label Indian companies. Show all posts
Friday, 22 January 2010
Indian pharma sector "fares well" in US disputes
India's Financial Express reports ("Domestic pharma cos fare well in patent litigation tests") on the pharma patent litigation success rates of India's leading pharmaceutical companies in US litigation over the past decade. Lupin Pharma has a success rate of 75%, while Sun Pharma (67%), Ranbaxy (63%) and Dr Reddy’s (61%) are not far behind. The article also gives a neat thumbnail sketch of the pharma patent litigation environment.
Subscribe to:
Posts (Atom)